ID	Description	GeneRatio	BgRatio	pvalue	p.adjust	qvalue	geneID	Count	kegg_link	kegg_link	kegg_link
hsa04060	Cytokine-cytokine receptor interaction	17/25	294/7946	2.39627E-19	1.86909E-17	1.23597E-17	CCL14/CCL19/CCL2/CCL3/CCL3L1/CCL3L3/CCR1/CXCL9/EPO/IL18R1/IL1B/IL1RL1/IL3/IL7R/NGFR/PRL/TNFRSF10D	17	http://www.kegg.jp/kegg-bin/show_pathway?hsa04060/CCL14%09red/CCL19%09red/CCL2%09red/CCL3%09blue/CCL3L1%09red/CCL3L3%09red/CCR1%09red/CXCL9%09red/EPO%09red/IL18R1%09red/IL1B%09red/IL1RL1%09red/IL3%09red/IL7R%09red/NGFR%09red/PRL%09red/TNFRSF10D%09red	http://www.kegg.jp/kegg-bin/show_pathway?hsa04060/CCL14%09red/CCL19%09red/CCL2%09red/CCL3%09blue/CCL3L1%09red/CCL3L3%09red/CCR1%09red/CXCL9%09red/EPO%09red/IL18R1%09red/IL1B%09red/IL1RL1%09red/IL3%09red/IL7R%09red/NGFR%09red/PRL%09red/TNFRSF10D%09red	http://www.kegg.jp/kegg-bin/show_pathway?hsa04060/CCL14%09red/CCL19%09red/CCL2%09red/CCL3%09blue/CCL3L1%09red/CCL3L3%09red/CCR1%09red/CXCL9%09red/EPO%09red/IL18R1%09red/IL1B%09red/IL1RL1%09red/IL3%09red/IL7R%09red/NGFR%09red/PRL%09red/TNFRSF10D%09red
hsa04061	Viral protein interaction with cytokine and cytokine receptor	10/25	100/7946	1.76158E-13	6.87015E-12	4.54302E-12	CCL14/CCL19/CCL2/CCL3/CCL3L1/CCL3L3/CCR1/CXCL9/IL18R1/TNFRSF10D	10	http://www.kegg.jp/kegg-bin/show_pathway?hsa04061/CCL14%09red/CCL19%09red/CCL2%09red/CCL3%09blue/CCL3L1%09red/CCL3L3%09red/CCR1%09red/CXCL9%09red/IL18R1%09red/TNFRSF10D%09red	http://www.kegg.jp/kegg-bin/show_pathway?hsa04061/CCL14%09red/CCL19%09red/CCL2%09red/CCL3%09blue/CCL3L1%09red/CCL3L3%09red/CCR1%09red/CXCL9%09red/IL18R1%09red/TNFRSF10D%09red	http://www.kegg.jp/kegg-bin/show_pathway?hsa04061/CCL14%09red/CCL19%09red/CCL2%09red/CCL3%09blue/CCL3L1%09red/CCL3L3%09red/CCR1%09red/CXCL9%09red/IL18R1%09red/TNFRSF10D%09red
hsa04933	AGE-RAGE signaling pathway in diabetic complications	8/25	100/7946	4.29728E-10	1.11729E-08	7.38831E-09	CCL2/COL1A1/COL3A1/EGR1/ICAM1/IL1B/SELE/VEGFC	8	http://www.kegg.jp/kegg-bin/show_pathway?hsa04933/CCL2%09red/COL1A1%09red/COL3A1%09red/EGR1%09red/ICAM1%09red/IL1B%09red/SELE%09red/VEGFC%09red	http://www.kegg.jp/kegg-bin/show_pathway?hsa04933/CCL2%09red/COL1A1%09red/COL3A1%09red/EGR1%09red/ICAM1%09red/IL1B%09red/SELE%09red/VEGFC%09red	http://www.kegg.jp/kegg-bin/show_pathway?hsa04933/CCL2%09red/COL1A1%09red/COL3A1%09red/EGR1%09red/ICAM1%09red/IL1B%09red/SELE%09red/VEGFC%09red
hsa04668	TNF signaling pathway	7/25	112/7946	3.56879E-08	6.95914E-07	4.60186E-07	CCL2/ICAM1/IL18R1/IL1B/JUNB/SELE/VEGFC	7	http://www.kegg.jp/kegg-bin/show_pathway?hsa04668/CCL2%09red/ICAM1%09red/IL18R1%09red/IL1B%09red/JUNB%09red/SELE%09red/VEGFC%09red	http://www.kegg.jp/kegg-bin/show_pathway?hsa04668/CCL2%09red/ICAM1%09red/IL18R1%09red/IL1B%09red/JUNB%09red/SELE%09red/VEGFC%09red	http://www.kegg.jp/kegg-bin/show_pathway?hsa04668/CCL2%09red/ICAM1%09red/IL18R1%09red/IL1B%09red/JUNB%09red/SELE%09red/VEGFC%09red
hsa04062	Chemokine signaling pathway	8/25	189/7946	6.75914E-08	1.05443E-06	6.97259E-07	CCL14/CCL19/CCL2/CCL3/CCL3L1/CCL3L3/CCR1/CXCL9	8	http://www.kegg.jp/kegg-bin/show_pathway?hsa04062/CCL14%09red/CCL19%09red/CCL2%09red/CCL3%09blue/CCL3L1%09red/CCL3L3%09red/CCR1%09red/CXCL9%09red	http://www.kegg.jp/kegg-bin/show_pathway?hsa04062/CCL14%09red/CCL19%09red/CCL2%09red/CCL3%09blue/CCL3L1%09red/CCL3L3%09red/CCR1%09red/CXCL9%09red	http://www.kegg.jp/kegg-bin/show_pathway?hsa04062/CCL14%09red/CCL19%09red/CCL2%09red/CCL3%09blue/CCL3L1%09red/CCL3L3%09red/CCR1%09red/CXCL9%09red
hsa05323	Rheumatoid arthritis	6/25	93/7946	3.23425E-07	4.20453E-06	2.78032E-06	CCL2/CCL3/CCL3L1/CCL3L3/ICAM1/IL1B	6	http://www.kegg.jp/kegg-bin/show_pathway?hsa05323/CCL2%09red/CCL3%09blue/CCL3L1%09red/CCL3L3%09red/ICAM1%09red/IL1B%09red	http://www.kegg.jp/kegg-bin/show_pathway?hsa05323/CCL2%09red/CCL3%09blue/CCL3L1%09red/CCL3L3%09red/ICAM1%09red/IL1B%09red	http://www.kegg.jp/kegg-bin/show_pathway?hsa05323/CCL2%09red/CCL3%09blue/CCL3L1%09red/CCL3L3%09red/ICAM1%09red/IL1B%09red
hsa04620	Toll-like receptor signaling pathway	6/25	104/7946	6.29369E-07	7.01296E-06	4.63745E-06	CCL3/CCL3L1/CCL3L3/CD14/CXCL9/IL1B	6	http://www.kegg.jp/kegg-bin/show_pathway?hsa04620/CCL3%09blue/CCL3L1%09red/CCL3L3%09red/CD14%09red/CXCL9%09red/IL1B%09red	http://www.kegg.jp/kegg-bin/show_pathway?hsa04620/CCL3%09blue/CCL3L1%09red/CCL3L3%09red/CD14%09red/CXCL9%09red/IL1B%09red	http://www.kegg.jp/kegg-bin/show_pathway?hsa04620/CCL3%09blue/CCL3L1%09red/CCL3L3%09red/CD14%09red/CXCL9%09red/IL1B%09red
hsa05132	Salmonella infection	5/25	80/7946	4.1372E-06	4.03377E-05	2.6674E-05	CCL3/CCL3L1/CCL3L3/CD14/IL1B	5	http://www.kegg.jp/kegg-bin/show_pathway?hsa05132/CCL3%09blue/CCL3L1%09red/CCL3L3%09red/CD14%09red/IL1B%09red	http://www.kegg.jp/kegg-bin/show_pathway?hsa05132/CCL3%09blue/CCL3L1%09red/CCL3L3%09red/CD14%09red/IL1B%09red	http://www.kegg.jp/kegg-bin/show_pathway?hsa05132/CCL3%09blue/CCL3L1%09red/CCL3L3%09red/CD14%09red/IL1B%09red
hsa04640	Hematopoietic cell lineage	5/25	99/7946	1.18253E-05	0.000102486	6.7771E-05	CD14/EPO/IL1B/IL3/IL7R	5	http://www.kegg.jp/kegg-bin/show_pathway?hsa04640/CD14%09red/EPO%09red/IL1B%09red/IL3%09red/IL7R%09red	http://www.kegg.jp/kegg-bin/show_pathway?hsa04640/CD14%09red/EPO%09red/IL1B%09red/IL3%09red/IL7R%09red	http://www.kegg.jp/kegg-bin/show_pathway?hsa04640/CD14%09red/EPO%09red/IL1B%09red/IL3%09red/IL7R%09red
hsa05142	Chagas disease (American trypanosomiasis)	5/25	102/7946	1.36842E-05	0.000106737	7.05817E-05	CCL2/CCL3/CCL3L1/CCL3L3/IL1B	5	http://www.kegg.jp/kegg-bin/show_pathway?hsa05142/CCL2%09red/CCL3%09blue/CCL3L1%09red/CCL3L3%09red/IL1B%09red	http://www.kegg.jp/kegg-bin/show_pathway?hsa05142/CCL2%09red/CCL3%09blue/CCL3L1%09red/CCL3L3%09red/IL1B%09red	http://www.kegg.jp/kegg-bin/show_pathway?hsa05142/CCL2%09red/CCL3%09blue/CCL3L1%09red/CCL3L3%09red/IL1B%09red
hsa05144	Malaria	4/25	50/7946	1.59225E-05	0.000112905	7.46604E-05	CCL2/ICAM1/IL1B/SELE	4	http://www.kegg.jp/kegg-bin/show_pathway?hsa05144/CCL2%09red/ICAM1%09red/IL1B%09red/SELE%09red	http://www.kegg.jp/kegg-bin/show_pathway?hsa05144/CCL2%09red/ICAM1%09red/IL1B%09red/SELE%09red	http://www.kegg.jp/kegg-bin/show_pathway?hsa05144/CCL2%09red/ICAM1%09red/IL1B%09red/SELE%09red
hsa05163	Human cytomegalovirus infection	6/25	225/7946	5.43704E-05	0.000353408	0.000233697	CCL2/CCL3/CCL3L1/CCL3L3/CCR1/IL1B	6	http://www.kegg.jp/kegg-bin/show_pathway?hsa05163/CCL2%09red/CCL3%09blue/CCL3L1%09red/CCL3L3%09red/CCR1%09red/IL1B%09red	http://www.kegg.jp/kegg-bin/show_pathway?hsa05163/CCL2%09red/CCL3%09blue/CCL3L1%09red/CCL3L3%09red/CCR1%09red/IL1B%09red	http://www.kegg.jp/kegg-bin/show_pathway?hsa05163/CCL2%09red/CCL3%09blue/CCL3L1%09red/CCL3L3%09red/CCR1%09red/IL1B%09red
hsa04151	PI3K-Akt signaling pathway	7/25	354/7946	7.86476E-05	0.000471886	0.000312043	COL1A1/EPO/IL3/IL7R/NGFR/PRL/VEGFC	7	http://www.kegg.jp/kegg-bin/show_pathway?hsa04151/COL1A1%09red/EPO%09red/IL3%09red/IL7R%09red/NGFR%09red/PRL%09red/VEGFC%09red	http://www.kegg.jp/kegg-bin/show_pathway?hsa04151/COL1A1%09red/EPO%09red/IL3%09red/IL7R%09red/NGFR%09red/PRL%09red/VEGFC%09red	http://www.kegg.jp/kegg-bin/show_pathway?hsa04151/COL1A1%09red/EPO%09red/IL3%09red/IL7R%09red/NGFR%09red/PRL%09red/VEGFC%09red
hsa05143	African trypanosomiasis	3/25	37/7946	0.00019922	0.00110994	0.000733969	ICAM1/IL1B/SELE	3	http://www.kegg.jp/kegg-bin/show_pathway?hsa05143/ICAM1%09red/IL1B%09red/SELE%09red	http://www.kegg.jp/kegg-bin/show_pathway?hsa05143/ICAM1%09red/IL1B%09red/SELE%09red	http://www.kegg.jp/kegg-bin/show_pathway?hsa05143/ICAM1%09red/IL1B%09red/SELE%09red
hsa04064	NF-kappa B signaling pathway	4/25	102/7946	0.000263143	0.001282823	0.00084829	CCL19/CD14/ICAM1/IL1B	4	http://www.kegg.jp/kegg-bin/show_pathway?hsa04064/CCL19%09red/CD14%09red/ICAM1%09red/IL1B%09red	http://www.kegg.jp/kegg-bin/show_pathway?hsa04064/CCL19%09red/CD14%09red/ICAM1%09red/IL1B%09red	http://www.kegg.jp/kegg-bin/show_pathway?hsa04064/CCL19%09red/CD14%09red/ICAM1%09red/IL1B%09red
hsa05146	Amoebiasis	4/25	102/7946	0.000263143	0.001282823	0.00084829	CD14/COL1A1/COL3A1/IL1B	4	http://www.kegg.jp/kegg-bin/show_pathway?hsa05146/CD14%09red/COL1A1%09red/COL3A1%09red/IL1B%09red	http://www.kegg.jp/kegg-bin/show_pathway?hsa05146/CD14%09red/COL1A1%09red/COL3A1%09red/IL1B%09red	http://www.kegg.jp/kegg-bin/show_pathway?hsa05146/CD14%09red/COL1A1%09red/COL3A1%09red/IL1B%09red
hsa05418	Fluid shear stress and atherosclerosis	4/25	139/7946	0.000852534	0.003911626	0.002586635	CCL2/ICAM1/IL1B/SELE	4	http://www.kegg.jp/kegg-bin/show_pathway?hsa05418/CCL2%09red/ICAM1%09red/IL1B%09red/SELE%09red	http://www.kegg.jp/kegg-bin/show_pathway?hsa05418/CCL2%09red/ICAM1%09red/IL1B%09red/SELE%09red	http://www.kegg.jp/kegg-bin/show_pathway?hsa05418/CCL2%09red/ICAM1%09red/IL1B%09red/SELE%09red
hsa04630	JAK-STAT signaling pathway	4/25	162/7946	0.0015074	0.006532066	0.00431945	EPO/IL3/IL7R/PRL	4	http://www.kegg.jp/kegg-bin/show_pathway?hsa04630/EPO%09red/IL3%09red/IL7R%09red/PRL%09red	http://www.kegg.jp/kegg-bin/show_pathway?hsa04630/EPO%09red/IL3%09red/IL7R%09red/PRL%09red	http://www.kegg.jp/kegg-bin/show_pathway?hsa04630/EPO%09red/IL3%09red/IL7R%09red/PRL%09red
hsa05020	Prion diseases	2/25	35/7946	0.00530643	0.021784293	0.014405268	EGR1/IL1B	2	http://www.kegg.jp/kegg-bin/show_pathway?hsa05020/EGR1%09red/IL1B%09red	http://www.kegg.jp/kegg-bin/show_pathway?hsa05020/EGR1%09red/IL1B%09red	http://www.kegg.jp/kegg-bin/show_pathway?hsa05020/EGR1%09red/IL1B%09red
hsa04926	Relaxin signaling pathway	3/25	129/7946	0.007405672	0.02888212	0.019098838	COL1A1/COL3A1/VEGFC	3	http://www.kegg.jp/kegg-bin/show_pathway?hsa04926/COL1A1%09red/COL3A1%09red/VEGFC%09red	http://www.kegg.jp/kegg-bin/show_pathway?hsa04926/COL1A1%09red/COL3A1%09red/VEGFC%09red	http://www.kegg.jp/kegg-bin/show_pathway?hsa04926/COL1A1%09red/COL3A1%09red/VEGFC%09red
hsa04010	MAPK signaling pathway	4/25	295/7946	0.012712898	0.047219335	0.031224661	CD14/IL1B/NGFR/VEGFC	4	http://www.kegg.jp/kegg-bin/show_pathway?hsa04010/CD14%09red/IL1B%09red/NGFR%09red/VEGFC%09red	http://www.kegg.jp/kegg-bin/show_pathway?hsa04010/CD14%09red/IL1B%09red/NGFR%09red/VEGFC%09red	http://www.kegg.jp/kegg-bin/show_pathway?hsa04010/CD14%09red/IL1B%09red/NGFR%09red/VEGFC%09red
hsa05134	Legionellosis	2/25	57/7946	0.013645216	0.048378494	0.031991177	CD14/IL1B	2	http://www.kegg.jp/kegg-bin/show_pathway?hsa05134/CD14%09red/IL1B%09red	http://www.kegg.jp/kegg-bin/show_pathway?hsa05134/CD14%09red/IL1B%09red	http://www.kegg.jp/kegg-bin/show_pathway?hsa05134/CD14%09red/IL1B%09red
hsa05164	Influenza A	3/25	170/7946	0.01566143	0.053112674	0.035121741	CCL2/ICAM1/IL1B	3	http://www.kegg.jp/kegg-bin/show_pathway?hsa05164/CCL2%09red/ICAM1%09red/IL1B%09red	http://www.kegg.jp/kegg-bin/show_pathway?hsa05164/CCL2%09red/ICAM1%09red/IL1B%09red	http://www.kegg.jp/kegg-bin/show_pathway?hsa05164/CCL2%09red/ICAM1%09red/IL1B%09red
hsa05321	Inflammatory bowel disease (IBD)	2/25	65/7946	0.017512909	0.056916955	0.037637393	IL18R1/IL1B	2	http://www.kegg.jp/kegg-bin/show_pathway?hsa05321/IL18R1%09red/IL1B%09red	http://www.kegg.jp/kegg-bin/show_pathway?hsa05321/IL18R1%09red/IL1B%09red	http://www.kegg.jp/kegg-bin/show_pathway?hsa05321/IL18R1%09red/IL1B%09red
hsa05221	Acute myeloid leukemia	2/25	67/7946	0.018544789	0.057859741	0.038260827	CD14/IL3	2	http://www.kegg.jp/kegg-bin/show_pathway?hsa05221/CD14%09red/IL3%09red	http://www.kegg.jp/kegg-bin/show_pathway?hsa05221/CD14%09red/IL3%09red	http://www.kegg.jp/kegg-bin/show_pathway?hsa05221/CD14%09red/IL3%09red
hsa05202	Transcriptional misregulation in cancer	3/25	186/7946	0.019877484	0.059632452	0.039433066	CD14/IL3/NGFR	3	http://www.kegg.jp/kegg-bin/show_pathway?hsa05202/CD14%09red/IL3%09red/NGFR%09red	http://www.kegg.jp/kegg-bin/show_pathway?hsa05202/CD14%09red/IL3%09red/NGFR%09red	http://www.kegg.jp/kegg-bin/show_pathway?hsa05202/CD14%09red/IL3%09red/NGFR%09red
hsa05133	Pertussis	2/25	76/7946	0.023496679	0.067879296	0.044886444	CD14/IL1B	2	http://www.kegg.jp/kegg-bin/show_pathway?hsa05133/CD14%09red/IL1B%09red	http://www.kegg.jp/kegg-bin/show_pathway?hsa05133/CD14%09red/IL1B%09red	http://www.kegg.jp/kegg-bin/show_pathway?hsa05133/CD14%09red/IL1B%09red
hsa04657	IL-17 signaling pathway	2/25	94/7946	0.034820287	0.095486631	0.063142306	CCL2/IL1B	2	http://www.kegg.jp/kegg-bin/show_pathway?hsa04657/CCL2%09red/IL1B%09red	http://www.kegg.jp/kegg-bin/show_pathway?hsa04657/CCL2%09red/IL1B%09red	http://www.kegg.jp/kegg-bin/show_pathway?hsa04657/CCL2%09red/IL1B%09red
hsa04974	Protein digestion and absorption	2/25	95/7946	0.03550144	0.095486631	0.063142306	COL1A1/COL3A1	2	http://www.kegg.jp/kegg-bin/show_pathway?hsa04974/COL1A1%09red/COL3A1%09red	http://www.kegg.jp/kegg-bin/show_pathway?hsa04974/COL1A1%09red/COL3A1%09red	http://www.kegg.jp/kegg-bin/show_pathway?hsa04974/COL1A1%09red/COL3A1%09red
hsa05135	Yersinia infection	2/25	120/7946	0.054136739	0.140755522	0.093077201	CCL2/IL1B	2	 	 	 
hsa04611	Platelet activation	2/25	124/7946	0.057384943	0.144387922	0.095479192	COL1A1/COL3A1	2	 	 	 
hsa04380	Osteoclast differentiation	2/25	128/7946	0.060700799	0.147958197	0.097840103	IL1B/JUNB	2	 	 	 
hsa04514	Cell adhesion molecules (CAMs)	2/25	147/7946	0.077313042	0.182739917	0.120840161	ICAM1/SELE	2	 	 	 
hsa01523	Antifolate resistance	1/25	31/7946	0.09323529	0.207781503	0.137399374	IL1B	1	 	 	 
hsa05310	Asthma	1/25	31/7946	0.09323529	0.207781503	0.137399374	IL3	1	 	 	 
hsa04215	Apoptosis - multiple species	1/25	32/7946	0.09609936	0.20821528	0.137686218	NGFR	1	 	 	 
hsa05152	Tuberculosis	2/25	180/7946	0.109079379	0.224621405	0.148535072	CD14/IL1B	2	 	 	 
hsa04621	NOD-like receptor signaling pathway	2/25	181/7946	0.110091455	0.224621405	0.148535072	CCL2/IL1B	2	 	 	 
hsa05340	Primary immunodeficiency	1/25	38/7946	0.113102267	0.224621405	0.148535072	IL7R	1	 	 	 
hsa05167	Kaposi sarcoma-associated herpesvirus infection	2/25	186/7946	0.115190464	0.224621405	0.148535072	CCR1/ICAM1	2	 	 	 
hsa05332	Graft-versus-host disease	1/25	41/7946	0.121488158	0.231123813	0.15283491	IL1B	1	 	 	 
hsa04940	Type I diabetes mellitus	1/25	43/7946	0.127036406	0.23351263	0.15441456	IL1B	1	 	 	 
hsa04510	Focal adhesion	2/25	199/7946	0.128731322	0.23351263	0.15441456	COL1A1/VEGFC	2	 	 	 
hsa04015	Rap1 signaling pathway	2/25	210/7946	0.140479037	0.24903102	0.164676383	NGFR/VEGFC	2	 	 	 
hsa05166	Human T-cell leukemia virus 1 infection	2/25	219/7946	0.150266572	0.260462057	0.172235369	EGR1/ICAM1	2	 	 	 
hsa04014	Ras signaling pathway	2/25	232/7946	0.164650361	0.279189742	0.184619398	NGFR/VEGFC	2	 	 	 
hsa05131	Shigellosis	2/25	236/7946	0.169128779	0.280681804	0.185606051	CD14/IL1B	2	 	 	 
hsa05416	Viral myocarditis	1/25	60/7946	0.172857589	0.280893583	0.185746094	ICAM1	1	 	 	 
hsa04623	Cytosolic DNA-sensing pathway	1/25	63/7946	0.180700227	0.28764526	0.190210766	IL1B	1	 	 	 
hsa04664	Fc epsilon RI signaling pathway	1/25	68/7946	0.193612902	0.302036127	0.199726994	IL3	1	 	 	 
hsa04917	Prolactin signaling pathway	1/25	70/7946	0.198723074	0.303929407	0.20097896	PRL	1	 	 	 
hsa05140	Leishmaniasis	1/25	77/7946	0.216364979	0.324547468	0.214613035	IL1B	1	 	 	 
hsa04512	ECM-receptor interaction	1/25	88/7946	0.243336839	0.358118367	0.236812416	COL1A1	1	 	 	 
hsa04912	GnRH signaling pathway	1/25	93/7946	0.255300031	0.368766711	0.24385383	EGR1	1	 	 	 
hsa05150	Staphylococcus aureus infection	1/25	96/7946	0.262390563	0.372117525	0.246069619	ICAM1	1	 	 	 
hsa04750	Inflammatory mediator regulation of TRP channels	1/25	100/7946	0.271743849	0.378500361	0.250290387	IL1B	1	 	 	 
hsa04625	C-type lectin receptor signaling pathway	1/25	104/7946	0.280983216	0.380086529	0.25133927	IL1B	1	 	 	 
hsa04928	Parathyroid hormone synthesis, secretion and action	1/25	106/7946	0.285560597	0.380086529	0.25133927	EGR1	1	 	 	 
hsa04659	Th17 cell differentiation	1/25	107/7946	0.287838784	0.380086529	0.25133927	IL1B	1	 	 	 
hsa04066	HIF-1 signaling pathway	1/25	109/7946	0.292374253	0.380086529	0.25133927	EPO	1	 	 	 
hsa04670	Leukocyte transendothelial migration	1/25	112/7946	0.299125503	0.382488348	0.252927517	ICAM1	1	 	 	 
hsa04722	Neurotrophin signaling pathway	1/25	119/7946	0.314638794	0.389552793	0.257599013	NGFR	1	 	 	 
hsa04935	Growth hormone synthesis, secretion and action	1/25	119/7946	0.314638794	0.389552793	0.257599013	JUNB	1	 	 	 
hsa04068	FoxO signaling pathway	1/25	131/7946	0.340469146	0.407323449	0.269350189	IL7R	1	 	 	 
hsa04650	Natural killer cell mediated cytotoxicity	1/25	131/7946	0.340469146	0.407323449	0.269350189	ICAM1	1	 	 	 
hsa04210	Apoptosis	1/25	136/7946	0.350953653	0.407323449	0.269350189	IL3	1	 	 	 
hsa04371	Apelin signaling pathway	1/25	137/7946	0.353031266	0.407323449	0.269350189	EGR1	1	 	 	 
hsa05162	Measles	1/25	138/7946	0.355102494	0.407323449	0.269350189	IL1B	1	 	 	 
hsa04932	Non-alcoholic fatty liver disease (NAFLD)	1/25	149/7946	0.377469913	0.426705119	0.282166678	IL1B	1	 	 	 
hsa04145	Phagosome	1/25	152/7946	0.383439666	0.427261342	0.282534491	CD14	1	 	 	 
hsa04217	Necroptosis	1/25	162/7946	0.402944497	0.442671419	0.29272469	IL1B	1	 	 	 
hsa05010	Alzheimer disease	1/25	171/7946	0.419991243	0.454990513	0.300870919	IL1B	1	 	 	 
hsa05168	Herpes simplex virus 1 infection	2/25	491/7946	0.463034755	0.491180964	0.324802527	CCL2/IL1B	2	 	 	 
hsa05169	Epstein-Barr virus infection	1/25	201/7946	0.473503953	0.491180964	0.324802527	ICAM1	1	 	 	 
hsa05130	Pathogenic Escherichia coli infection	1/25	202/7946	0.475203424	0.491180964	0.324802527	IL1B	1	 	 	 
hsa05205	Proteoglycans in cancer	1/25	204/7946	0.47858658	0.491180964	0.324802527	COL1A1	1	 	 	 
hsa05165	Human papillomavirus infection	1/25	330/7946	0.65426177	0.662758677	0.438261473	COL1A1	1	 	 	 
hsa04080	Neuroactive ligand-receptor interaction	1/25	340/7946	0.665451177	0.665451177	0.440041939	PRL	1	 	 	 
